The acute phase response inhibits reverse cholesterol transport

Journal of Lipid Research

Volumn 51, Issue 4, 2010, Pages 682-684

  Feingold, Kenneth R ^a   Grunfeld, Carl ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1 ALKYL 2 ACETYLGLYCEROPHOSPHOCHOLINE ESTERASE; ABC TRANSPORTER; ACUTE PHASE PROTEIN; APOLIPOPROTEIN A; ARYLDIALKYLPHOSPHATASE 1; C REACTIVE PROTEIN; CERAMIDE; CHOLESTEROL; CHOLESTEROL ESTER TRANSFER PROTEIN; GLUCOSYLCERAMIDE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPOLYSACCHARIDE; LIVER PROTEIN; PHOSPHOLIPASE A2; PLASMA PROTEIN; SERUM AMYLOID A; TRIACYLGLYCEROL; BILE ACID; LIPOPROTEIN; PEROXIDASE; PHOSPHOLIPASE A2 GROUP II;

ACUTE PHASE RESPONSE; ATHEROSCLEROSIS; CHOLESTEROL TRANSPORT; DISEASE ASSOCIATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INHIBITION KINETICS; LIPID METABOLISM; LIPID OXIDATION; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NOTE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; PSORIASIS; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SYSTEMIC LUPUS ERYTHEMATOSUS; TOOTH INFECTION; ANIMAL; BLOOD; CHEMICALLY INDUCED; CHEMISTRY; FECES; LIVER; MACROPHAGE; METABOLISM; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; SECRETION (PROCESS); TOXICITY; TRANSPORT AT THE CELLULAR LEVEL;

ACUTE-PHASE REACTION; ANIMALS; ATHEROSCLEROSIS; BILE ACIDS AND SALTS; BIOLOGICAL TRANSPORT; CHOLESTEROL; FECES; GROUP II PHOSPHOLIPASES A2; HUMANS; LIPOPOLYSACCHARIDES; LIPOPROTEINS; LIPOPROTEINS, HDL; LIVER; MACROPHAGES; MICE; PEROXIDASE; SERUM AMYLOID A PROTEIN;

EID: 77950604154     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.E005454     Document Type: Note

References (28)

1. Gabay, C., and I. Kushner 1999. Acute-phase proteins and other systemic responses to infl ammation. N. Engl. J. Med. 340: 448-454. (Pubitemid 29084777)
2. Hotamisligil, G. S. 2006. Infl ammation and metabolic disorders. Nature. 444: 860-867.
3. Khovidhunkit, W., M. S. Kim, R. A. Memon, J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2004. Effects of infection and infl ammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J. Lipid Res. 45: 1169-1196. (Pubitemid 38802622)
4. Feingold, K. R., R. A. Memon, A. H. Moser, and C. Grunfeld. 1998. Paraoxonase activity in the serum and hepatic mRNA levels decrease during the acute phase response. Atherosclerosis. 139: 307-315. (Pubitemid 28361815)
5. Van Lenten, B. J., S. Y. Hama, F. C. de Beer, D. M. Stafforini, T. M. McIntyre, S. M. Prescott, B. N. La Du, A. M. Fogelman, and M. Navab. 1995. Anti-infl ammatory HDL becomes pro-infl ammatory during the acute phase response. Loss of protective effect of HDL against LDL oxidation in aortic wall cell cocultures. J. Clin. Invest. 96: 2758-2767.
6. Cao, Y., D. M. Stafforini, G. A. Zimmerman, T. M. McIntyre, and S. M. Prescott. 1998. Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of infl ammation. J. Biol. Chem. 273: 4012-4020. (Pubitemid 28103265)
7. Memon, R. A., J. Fuller, A. H. Moser, K. R. Feingold, and C. Grunfeld. 1999. In vivo regulation of plasma platelet-activating factor acetylhydrolase during the acute phase response. Am. J. Physiol. 277: R94-R103. (Pubitemid 29356782)
8. Navab, M., G. M. Anantharamaiah, S. T. Reddy, B. J. Van Lenten, and A. M. Fogelman. 2009. HDL as a biomarker, potential therapeutic target, and therapy. Diabetes. 58: 2711-2717.
9. Banka, C. L., T. Yuan, M. C. de Beer, M. Kindy, L. K. Curtiss, and F. C. de Beer. 1995. Serum amyloid A (SAA): infl uence on HDL-mediated cellular cholesterol effl ux. J. Lipid Res. 36: 1058-1065.
10. Khovidhunkit, W., J. K. Shigenaga, A. H. Moser, K. R. Feingold, and C. Grunfeld. 2001. Cholesterol effl ux by acute-phase high density lipoprotein: role of lecithin: cholesterol acyltransferase. J. Lipid Res. 42: 967-975. (Pubitemid 32545853)
11. McGillicuddy, F. C., M. de la Llera Moya, C. C. Hinkle, M. R. Joshi, E. H. Chiquoine, J. T. Billheimer, G. H. Rothblat, and M. P. Reilly. 2009. Infl ammation impairs reverse cholesterol transport in vivo. Circulation. 119: 1135-1145.
12. Pussinen, P. J., M. Jauhiainen, T. Vilkuna-Rautiainen, J. Sundvall, M. Vesanen, K. Mattila, T. Palosuo, G. Alfthan, and S. Asikainen. 2004. Periodontitis decreases the antiatherogenic potency of high density lipoprotein. J. Lipid Res. 45: 139-147. (Pubitemid 38176624)
13. Annema, W., N. Nijstad, M. Tolle, J. F. de Boer, R. V. Buijs, P. Heeringa, M. van der Giet, and U. J. Tietge. 2010. Myeloperoxidase and serum amyloid A contribute to impaired in vivo reverse cholesterol transport during the acute phase response, but not group IIA secretory phospholipase A2. J. Lipid Res. 51: 743-754.
14. Baranova, I., T. Vishnyakova, A. Bocharov, Z. Chen, A. T. Remaley, J. Stonik, T. L. Eggerman, and A. P. Patterson. 2002. Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect. Immun. 70: 2995-3003. (Pubitemid 34564159)
15. Buechler, C., M. Ritter, C. D. Quoc, A. Agildere, and G. Schmitz. 1999. Lipopolysaccharide inhibits the expression of the scavenger receptor Cla-1 in human monocytes and macrophages. Biochem. Biophys. Res. Commun. 262: 251-254. (Pubitemid 29412655)
16. Khovidhunkit, W., A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold. 2003. Endotoxin down-regulates ABCG5 and ABCG8 in mouse liver and ABCA1 and ABCG1 in J774 murine mac-rophages: differential role of LXR. J. Lipid Res. 44: 1728-1736. (Pubitemid 37185884)
17. Gafencu, A. V., M. R. Robciuc, E. Fuior, V. I. Zannis, D. Kardassis, and M. Simionescu. 2007. Infl ammatory signaling pathways regulating ApoE gene expression in macrophages. J. Biol. Chem. 282: 21776-21785. (Pubitemid 47195771)
18. Werb, Z., and J. R. Chin. 1983. Endotoxin suppresses expression of apoprotein E by mouse macrophages in vivo and in culture. A biochemical and genetic study. J. Biol. Chem. 258: 10642-10648. (Pubitemid 14244325)
19. Auerbach, B. J., and J. S. Parks. 1989. Lipoprotein abnormalities associated with lipopolysaccharide-induced lecithin: cholesterol acyl-transferase and lipase defi ciency. J. Biol. Chem. 264: 10264-10270.
20. Ly, H., O. L. Francone, C. J. Fielding, J. K. Shigenaga, A. H. Moser, C. Grunfeld, and K. R. Feingold. 1995. Endotoxin and TNF lead to reduced plasma LCAT activity and decreased hepatic LCAT mRNA levels in Syrian hamsters. J. Lipid Res. 36: 1254-1263.
21. Hardardottir, I., A. H. Moser, J. Fuller, C. Fielding, K. Feingold, and C. Grunfeld. 1996. Endotoxin and cytokines decrease serum levels and extra hepatic protein and mRNA levels of choles-teryl ester transfer protein in syrian hamsters. J. Clin. Invest. 97: 2585-2592. (Pubitemid 26187346)
22. Masucci-Magoulas, L., P. Moulin, X. C. Jiang, H. Richardson, A. Walsh, J. L. Breslow, and A. Tall. 1995. Decreased cholesteryl ester transfer protein (CETP) mRNA and protein and increased high density lipoprotein following lipopolysaccharide administration in human CETP transgenic mice. J. Clin. Invest. 95: 1587-1594.
23. Khovidhunkit, W., A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold. 2001. Regulation of scavenger receptor class B type I in hamster liver and Hep3B cells by endotoxin and cytokines. J. Lipid Res. 42: 1636-1644. (Pubitemid 33020096)
24. Dikopoulos, N., H. Weidenbach, G. Adler, and R. M. Schmid. 2003. Lipopolysaccharide represses cholesterol 7-alpha hydroxylase and induces binding activity to the bile acid response element II. Eur. J. Clin. Invest. 33: 58-64. (Pubitemid 36051292)
25. Feingold, K. R., D. K. Spady, A. S. Pollock, A. H. Moser, and C. Grunfeld. 1996. Endotoxin, TNF, and IL-1 decrease cholesterol 7 alpha-hydroxylase mRNA levels and activity. J. Lipid Res. 37: 223-228. (Pubitemid 26078941)
26. Memon, R. A., A. H. Moser, J. K. Shigenaga, C. Grunfeld, and K. R. Feingold. 2001. In vivo and in vitro regulation of sterol 27-hydrox-ylase in the liver during the acute phase response. Potential role of hepatocyte nuclear factor-1. J. Biol. Chem. 276: 30118-30126.
27. Hartmann, G., A. K. Cheung, and M. Piquette-Miller. 2002. Infl ammatory cytokines, but not bile acids, regulate expression of murine hepatic anion transporters in endotoxemia. J. Pharmacol. Exp. Ther. 303: 273-281.
28. Vos, T. A., G. J. Hooiveld, H. Koning, S. Childs, D. K. Meijer, H. Moshage, P. L. Jansen, and M. Muller. 1998. Up-regulation of the multidrug resistance genes, Mrp1 and Mdr1b, and down-regulation of the organic anion transporter, Mrp2, and the bile salt transporter, Spgp, in endotoxemic rat liver. Hepatology. 28: 1637-1644. (Pubitemid 28549135)